Advertisement

Index by author

December 01, 2003; Volume 31,Issue 12

B

  1. Boobis, Alan R.

    1. A STRATEGY FOR INVESTIGATING THE CYP SUPERFAMILY USING TARGETED ANTIBODIES IS A PARADIGM FOR FUNCTIONAL GENOMIC STUDIES
      Robert J. Edwards, Alan R. Boobis and Donald S. Davies
      Drug Metabolism and Disposition December 2003, 31 (12) 1476-1480; DOI: https://doi.org/10.1124/dmd.31.12.1476

C

  1. Cook, Jack

    1. A SIGNIFICANT DRUG-METABOLIZING ROLE FOR CYP3A5?
      J. Andrew Williams, Jack Cook and Susan I. Hurst
      Drug Metabolism and Disposition December 2003, 31 (12) 1526-1530; DOI: https://doi.org/10.1124/dmd.31.12.1526

D

  1. Davies, Donald S.

    1. A STRATEGY FOR INVESTIGATING THE CYP SUPERFAMILY USING TARGETED ANTIBODIES IS A PARADIGM FOR FUNCTIONAL GENOMIC STUDIES
      Robert J. Edwards, Alan R. Boobis and Donald S. Davies
      Drug Metabolism and Disposition December 2003, 31 (12) 1476-1480; DOI: https://doi.org/10.1124/dmd.31.12.1476

E

  1. Edwards, Robert J.

    1. A STRATEGY FOR INVESTIGATING THE CYP SUPERFAMILY USING TARGETED ANTIBODIES IS A PARADIGM FOR FUNCTIONAL GENOMIC STUDIES
      Robert J. Edwards, Alan R. Boobis and Donald S. Davies
      Drug Metabolism and Disposition December 2003, 31 (12) 1476-1480; DOI: https://doi.org/10.1124/dmd.31.12.1476

  2. Estabrook, Ronald W.

    1. A TRIBUTE TO JAMES ROBERT GILLETTE
      Ronald W. Estabrook
      Drug Metabolism and Disposition December 2003, 31 (12) 1459-1460; DOI: https://doi.org/10.1124/dmd.31.12.1459
    2. A PASSION FOR P450s (REMEMBRANCES OF THE EARLY HISTORY OF RESEARCH ON CYTOCHROME P450)
      Ronald W. Estabrook
      Drug Metabolism and Disposition December 2003, 31 (12) 1461-1473; DOI: https://doi.org/10.1124/dmd.31.12.1461

H

  1. Hinson, Jack A.

    1. ACETAMINOPHEN-INDUCED HEPATOTOXICITY
      Laura P. James, Philip R. Mayeux and Jack A. Hinson
      Drug Metabolism and Disposition December 2003, 31 (12) 1499-1506; DOI: https://doi.org/10.1124/dmd.31.12.1499

  2. Hurst, Susan I.

    1. A SIGNIFICANT DRUG-METABOLIZING ROLE FOR CYP3A5?
      J. Andrew Williams, Jack Cook and Susan I. Hurst
      Drug Metabolism and Disposition December 2003, 31 (12) 1526-1530; DOI: https://doi.org/10.1124/dmd.31.12.1526

J

  1. James, Laura P.

    1. ACETAMINOPHEN-INDUCED HEPATOTOXICITY
      Laura P. James, Philip R. Mayeux and Jack A. Hinson
      Drug Metabolism and Disposition December 2003, 31 (12) 1499-1506; DOI: https://doi.org/10.1124/dmd.31.12.1499

  2. Johnson, Eric F.

    1. THE 2002 BERNARD B. BRODIE AWARD LECTURE
      Eric F. Johnson
      Drug Metabolism and Disposition December 2003, 31 (12) 1532-1540; DOI: https://doi.org/10.1124/dmd.31.12.1532

K

  1. Kaminsky, Laurence S.

    1. THE SMALL INTESTINE AS A XENOBIOTIC-METABOLIZING ORGAN
      Laurence S. Kaminsky and Qing-Yu Zhang
      Drug Metabolism and Disposition December 2003, 31 (12) 1520-1525; DOI: https://doi.org/10.1124/dmd.31.12.1520

  2. Kato, Ryuichi

    1. MY WARM MEMORIES OF JAMES R. GILLETTE
      Ryuichi Kato
      Drug Metabolism and Disposition December 2003, 31 (12) 1474; DOI: https://doi.org/10.1124/dmd.31.12.1474

M

  1. Mayeux, Philip R.

    1. ACETAMINOPHEN-INDUCED HEPATOTOXICITY
      Laura P. James, Philip R. Mayeux and Jack A. Hinson
      Drug Metabolism and Disposition December 2003, 31 (12) 1499-1506; DOI: https://doi.org/10.1124/dmd.31.12.1499

N

  1. Nelson, Sidney D.

    1. THE USE OF DEUTERIUM ISOTOPE EFFECTS TO PROBE THE ACTIVE SITE PROPERTIES, MECHANISM OF CYTOCHROME P450-CATALYZED REACTIONS, AND MECHANISMS OF METABOLICALLY DEPENDENT TOXICITY
      Sidney D. Nelson and William F. Trager
      Drug Metabolism and Disposition December 2003, 31 (12) 1481-1497; DOI: https://doi.org/10.1124/dmd.31.12.1481

P

  1. Pang, K. Sandy

    1. MODELING OF INTESTINAL DRUG ABSORPTION: ROLES OF TRANSPORTERS AND METABOLIC ENZYMES (FOR THE GILLETTE REVIEW SERIES)
      K. Sandy Pang
      Drug Metabolism and Disposition December 2003, 31 (12) 1507-1519; DOI: https://doi.org/10.1124/dmd.31.12.1507

T

  1. Trager, William F.

    1. THE USE OF DEUTERIUM ISOTOPE EFFECTS TO PROBE THE ACTIVE SITE PROPERTIES, MECHANISM OF CYTOCHROME P450-CATALYZED REACTIONS, AND MECHANISMS OF METABOLICALLY DEPENDENT TOXICITY
      Sidney D. Nelson and William F. Trager
      Drug Metabolism and Disposition December 2003, 31 (12) 1481-1497; DOI: https://doi.org/10.1124/dmd.31.12.1481

W

  1. Williams, J. Andrew

    1. A SIGNIFICANT DRUG-METABOLIZING ROLE FOR CYP3A5?
      J. Andrew Williams, Jack Cook and Susan I. Hurst
      Drug Metabolism and Disposition December 2003, 31 (12) 1526-1530; DOI: https://doi.org/10.1124/dmd.31.12.1526

Z

  1. Zhang, Qing-Yu

    1. THE SMALL INTESTINE AS A XENOBIOTIC-METABOLIZING ORGAN
      Laurence S. Kaminsky and Qing-Yu Zhang
      Drug Metabolism and Disposition December 2003, 31 (12) 1520-1525; DOI: https://doi.org/10.1124/dmd.31.12.1520
Back to top

In this issue